Deregulated MAPK activity prevents adipocyte differentiation of fibroblasts lacking the retinoblastoma protein

Jacob B Hansen1, Rasmus K Petersen, Claus Jørgensen

  • 1Department of Biochemistry and Molecular Biology, Center for Experimental BioInformatics, University of Southern Denmark, DK-5230 Odense M, Denmark.

Insights

A functional retinoblastoma protein (pRB) is crucial for adipocyte differentiation. Loss of pRB elevates Ras activity, increasing MAPK signaling and inhibiting fat cell development.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • A functional retinoblastoma protein (pRB) is essential for adipogenesis.
  • Loss of pRB in mouse embryo fibroblasts (MEFs) correlates with elevated Ras activity.
  • Ras-dependent signaling pathways, including MAPK, have complex roles in adipocyte differentiation.

Purpose of the Study:

  • To investigate the role of pRB in regulating Ras-MAPK signaling during adipogenesis.
  • To determine how pRB deficiency impacts adipocyte differentiation.
  • To elucidate the mechanism by which pRB influences adipogenic signaling pathways.

Main Methods:

  • Utilized pRB-deficient MEFs and standard adipogenic inducers.
  • Assessed levels of activated Ras, ERK1/2, and PKB/Akt.
  • Employed the MEK inhibitor UO126 to suppress ERK1/2 activation.
  • Monitored adipocyte marker gene expression and lipid accumulation.

Main Results:

  • pRB-deficient MEFs exhibited increased levels of activated Ras, ERK1/2, and PKB/Akt.
  • Inhibition of ERK1/2 activation using UO126 rescued the adipogenic differentiation defect in pRB-deficient MEFs.
  • Adipocyte differentiation in pRB-deficient MEFs occurred independently of insulin due to elevated PKB/Akt activity.

Conclusions:

  • pRB plays a critical role in adipogenesis by suppressing MAPK activity.
  • Aberrant MAPK signaling in pRB-deficient cells contributes to impaired adipocyte differentiation.
  • Targeting MAPK pathways could be a strategy to modulate adipogenesis in pRB-deficient contexts.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...